Inga V. Leus

996 total citations
28 papers, 649 citations indexed

About

Inga V. Leus is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Inga V. Leus has authored 28 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Medicine, 11 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Inga V. Leus's work include Antibiotic Resistance in Bacteria (20 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Inga V. Leus is often cited by papers focused on Antibiotic Resistance in Bacteria (20 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Inga V. Leus collaborates with scholars based in United States, Italy and Ukraine. Inga V. Leus's co-authors include Helen I. Zgurskaya, Valentin V. Rybenkov, Jon W. Weeks, Ganesh Krishnamoorthy, David Wolloscheck, Vincent Bonifay, Lauren A. Smith, Justyna Adamiak, Mohammad Moniruzzaman and Robert K. Ernst and has published in prestigious journals such as Chemical Reviews, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Inga V. Leus

26 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inga V. Leus United States 14 457 238 165 121 102 28 649
Jon W. Weeks United States 12 405 0.9× 180 0.8× 116 0.7× 177 1.5× 94 0.9× 16 556
David Wolloscheck United States 7 392 0.9× 211 0.9× 124 0.8× 153 1.3× 64 0.6× 7 557
Nichole K. Stewart United States 14 584 1.3× 326 1.4× 259 1.6× 99 0.8× 153 1.5× 29 822
Hilary Frase United States 18 544 1.2× 389 1.6× 230 1.4× 97 0.8× 152 1.5× 28 812
Jarrod E. Voss Australia 6 290 0.6× 304 1.3× 82 0.5× 190 1.6× 80 0.8× 7 593
Nathan R. James United Kingdom 3 280 0.6× 266 1.1× 78 0.5× 166 1.4× 72 0.7× 5 536
Eiji Nikaido Japan 7 413 0.9× 277 1.2× 86 0.5× 153 1.3× 222 2.2× 8 742
Hiroyuki Akama Japan 8 336 0.7× 283 1.2× 91 0.6× 196 1.6× 98 1.0× 16 639
Yuiko Takebayashi United Kingdom 8 539 1.2× 235 1.0× 202 1.2× 56 0.5× 120 1.2× 14 761
Lorenz Brandstätter Switzerland 6 449 1.0× 290 1.2× 129 0.8× 196 1.6× 48 0.5× 6 695

Countries citing papers authored by Inga V. Leus

Since Specialization
Citations

This map shows the geographic impact of Inga V. Leus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga V. Leus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga V. Leus more than expected).

Fields of papers citing papers by Inga V. Leus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inga V. Leus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga V. Leus. The network helps show where Inga V. Leus may publish in the future.

Co-authorship network of co-authors of Inga V. Leus

This figure shows the co-authorship network connecting the top 25 collaborators of Inga V. Leus. A scholar is included among the top collaborators of Inga V. Leus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inga V. Leus. Inga V. Leus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saral, Ayşegül, Inga V. Leus, Mithila Farjana, et al.. (2025). Mutations in the proximal binding site and F-loop of AdeJ confer resistance to efflux pump inhibitors. Antimicrobial Agents and Chemotherapy. 69(8). e0009025–e0009025.
2.
Leus, Inga V. & Helen I. Zgurskaya. (2025). No two are alike: on the role of Klebsiella pneumoniae permeability barriers in antibiotic susceptibility and persistence. Antimicrobial Agents and Chemotherapy. 69(8). e0008525–e0008525.
3.
Manrique, Pedro D., Inga V. Leus, César A. López, et al.. (2024). Predicting permeation of compounds across the outer membrane of P. aeruginosa using molecular descriptors. Communications Chemistry. 7(1). 84–84. 4 indexed citations
4.
Saral, Ayşegül, et al.. (2024). AdeIJK Pump-Specific Inhibitors Effective against Multidrug Resistant Acinetobacter baumannii. ACS Infectious Diseases. 10(6). 2239–2249. 4 indexed citations
5.
Cao, Feng, et al.. (2023). Identification and structure–activity relationships for a series of N, N-disubstituted 2-aminobenzothiazoles as potent inhibitors of S. aureus. Bioorganic & Medicinal Chemistry Letters. 89. 129301–129301. 7 indexed citations
6.
Gervasoni, Silvia, Jitender Mehla, Inga V. Leus, et al.. (2023). Molecular determinants of avoidance and inhibition of Pseudomonas aeruginosa MexB efflux pump. mBio. 14(4). e0140323–e0140323. 8 indexed citations
8.
Leus, Inga V., et al.. (2023). Nonadditive functional interactions between ligand-binding sites of the multidrug efflux pump AdeB from Acinetobacter baumannii. Journal of Bacteriology. 206(1). e0021723–e0021723. 7 indexed citations
10.
Zgurskaya, Helen I., Justyna Adamiak, & Inga V. Leus. (2022). Making sense of drug-efflux transporters in the physiological environment. Current Opinion in Microbiology. 69. 102179–102179. 17 indexed citations
11.
Leus, Inga V., Jon W. Weeks, Vincent Bonifay, et al.. (2022). Property space mapping of Pseudomonas aeruginosa permeability to small molecules. Scientific Reports. 12(1). 8220–8220. 14 indexed citations
12.
Leus, Inga V., et al.. (2022). Structure–Uptake Relationship Studies of Oxazolidinones in Gram-Negative ESKAPE Pathogens. Journal of Medicinal Chemistry. 65(20). 14144–14179. 13 indexed citations
13.
Adamiak, Justyna, Vincent Bonifay, Courtney E. Chandler, et al.. (2021). Loss of RND-Type Multidrug Efflux Pumps Triggers Iron Starvation and Lipid A Modifications in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 65(10). e0059221–e0059221. 23 indexed citations
14.
Moniruzzaman, Mohammad, Giuliano Malloci, Connor J. Cooper, et al.. (2021). Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides. ACS Infectious Diseases. 7(9). 2650–2665. 16 indexed citations
15.
Fabre, Lucien, Inga V. Leus, Jon W. Weeks, et al.. (2020). A “Drug Sweeping” State of the TriABC Triclosan Efflux Pump from Pseudomonas aeruginosa. Structure. 29(3). 261–274.e6. 19 indexed citations
16.
Leus, Inga V., Vincent Bonifay, Helen I. Zgurskaya, et al.. (2019). First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(14). 1836–1841. 13 indexed citations
17.
Hazel, Anthony, Inga V. Leus, Jerry M. Parks, et al.. (2019). Conformational Dynamics of AcrA Govern Multidrug Efflux Pump Assembly. ACS Infectious Diseases. 5(11). 1926–1935. 22 indexed citations
18.
Leus, Inga V., et al.. (2018). Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii. Journal of Bacteriology. 200(13). 87 indexed citations
19.
Zgurskaya, Helen I., Valentin V. Rybenkov, Ganesh Krishnamoorthy, & Inga V. Leus. (2018). Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier. Research in Microbiology. 169(7-8). 351–356. 40 indexed citations
20.
Leus, Inga V., et al.. (2016). Changes in oxidative stress intensity in blood of tumor-bearing rats following different modes of administration of rhenium-platinum system. The Ukrainian Biochemical Journal. 88(4). 29–39. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026